While a cure remains elusive, cancer treatment has seen significant advances in recent years. New innovations include ...

Daiichi Sankyo's upcoming AVANZAR study is critical for the stock, as success would unlock billions in revenue and accelerate ...

The rapid pace of digitalization has created a skills gap, necessitating that staff with traditional chemistry or biology ...

Drs Kathy Miller and Sunil Badve discuss how HER2 testing has evolved over time as the need for that clinical testing has shifted, including assay limits, biology, and clinical impact.

To My Shabbat Soul, I owe you an apology. For years you stood at the corner of my week, softly waving, while I sprinted past ...

U.S. FDA Fast Track designation granted to AKY-11891 for the treatment of adult patients with locally advanced or metastatic urothelial cancer ...

In early January, the U.S. Department of Health and Human Services removed the recommendation for universal vaccination ...

Coherus BioSciences shows underwhelming LOQTORZI sales and reliance on upcoming pipeline catalysts. Read why CHRS stock is ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

For the last three years, Bayer has been implementing a new strategy for its oncology development, a strategy that led to multiple approvals, as well as a number of promising new programmes added to ...

As demands for aseptic manufacturing increase, partnerships with solutions providers will be key to ensuring safe, versatile and optimized drug containment.

Over the past years, I have closely followed the evolution of the global oncology industry. What I have observed is steady, ...